Pyrrhocoricin, a proline-rich antimicrobial peptide derived from insect, inhibits the translation process in the cell-free Escherichia coli protein synthesis system

Journal of Bioscience and Bioengineering

Volumn 121, Issue 5, 2016, Pages 591-598

  Taniguchi, Masayuki ^a   Ochiai, Akihito ^a   Kondo, Hiroshi ^a   Fukuda, Shun ^a   Ishiyama, Yohei ^a   Saitoh, Eiichi ^b   Kato, Tetsuo ^c   Tanaka, Takaaki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA INSTITUTE OF TECHNOLOGY   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Antimicrobial peptide; Cell free translation system; Inhibition of protein synthesis; Intracellular target; Mechanism of action; Pyrrhocoricin

Indexed keywords

ANTIBIOTICS; ELECTROPHORESIS; ESCHERICHIA COLI; GENE EXPRESSION; MICROORGANISMS; PEPTIDES; POLYPEPTIDES; PROTEINS; SODIUM DODECYL SULFATE; SODIUM SULFATE; SYNTHESIS (CHEMICAL); TRANSCRIPTION;

ANTIMICROBIAL PEPTIDE; CELL-FREE TRANSLATION SYSTEMS; MECHANISM OF ACTION; PROTEIN SYNTHESIS; PYRRHOCORICIN;

BIOSYNTHESIS;

BLEOMYCIN; ESCHERICHIA COLI PROTEIN; FOSFOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PYRRHOCORICIN; STREPTOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; GREEN FLUORESCENT PROTEIN; INSECT PROTEIN; MESSENGER RNA; PROLINE; PYRRHOCORICIN PROTEIN, PYRRHOCORIS APTERUS;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISSOCIATION CONSTANT; ESCHERICHIA COLI; GENE EXPRESSION; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SURFACE PLASMON RESONANCE; ANIMAL; BIOSYNTHESIS; CELL FREE SYSTEM; CHEMISTRY; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; INSECT; METABOLISM; REPRODUCIBILITY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLEOMYCIN; CELL-FREE SYSTEM; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GREEN FLUORESCENT PROTEINS; IN VITRO TECHNIQUES; INSECT PROTEINS; INSECTS; PROLINE; PROTEIN BIOSYNTHESIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; STREPTOMYCIN; TRANSCRIPTION, GENETIC;

EID: 84961211876     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2015.09.002     Document Type: Article

References (51)

1. Auvynet C., Rosenstein Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J. 2009, 276:6497-6508.
2. Brown K.L., Hancock R.E.W. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 2006, 18:24-30.
3. Hale J.D.F., Hancock R.E.W. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti. Infect. Ther. 2007, 5:951-959.
4. Nicolas P. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J. 2009, 276:6483-6496.
5. Nguyen L.T., Haney E.F., Vogel H.J. The expanding scope of antimicrobial peptide strutures and their modes of action. Trends Biotechnol. 2011, 29:464-472.
6. Sarika, Iquebal M.A., Rai A. Biotic stress resistance in agriculture through antimicrobial peptides. Peptides 2012, 36:322-330.
7. Wu M., Maier E., Benz R., Hannock R.E.W. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999, 38:7235-7242.
8. Alba A., López-Abarrategui C., Otero-González A.J. Host defense peptides; an alternative as antiinfective and immunomodulatory therapeutics. Pept. Sci. 2012, 98:251-267.
9. Legrand B., Laurencin M., Sarkis J., Duval E., Mouret L., Hubert J.F., Collen M., Vié V., Zatylny-Gaudin C., other 3 authors Structure and mechanism of action a de novo antimicrobial detergent-like peptide. Biochim. Biophys. Acta 2011, 1808:106-116.
10. Nguyen L.T., de Boer L., Zaat S.A., Vogel H.J. Investigating the cationic side chains of the antimicrobial peptide tritrpticin: hydrogen bonding properties govern its membrane-disruptive activities. Biochim. Biophys. Acta 2011, 1808:2297-2303.
11. Borgden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
12. Otvos L. Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci. 2005, 11:697-706.
13. Hsu C.-H., Chen C., Jou M.-L., Lee A.Y.-L., Lin Y.-C., Yu Y.-P., Huang W.-T., Wu S.-H. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res. 2005, 33:4053-4061.
14. Rozgonyi F., Szabo D., Kocsis B., Osterházi E., Abbadessa G., Cassone M., Wade J.D., Otvos L. The antibacterial effect of a proline-rich antibacterial peptide A3-APO. Curr. Med. Chem. 2009, 16:3396-4002.
15. Scocchi M., Tossi A., Gennaro R. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell. Mol. Life Sci. 2011, 68:2317-2330.
16. Li W., Taihades J., O'Brien-Simpson N.M., Separovic F., Otvos L., Hossain M.A., Wade J.D. Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria. Amino Acids 2014, 46:2287-2294.
17. Park C.B., Kim M.S., Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular function. Biochem. Biophys. Res. Commun. 1998, 244:253-257.
18. Boman H.G., Agerberth B., Boman A. Mechanism of action in Escherichia coli of cecorpin P1 and PR-38, two antibacterial peptide from pig intestine. Infect. Immun. 1993, 61:2978-2984.
19. Haney E.F., Petersen A.P., Lau C.K., Jing W., Storey D.G., Vogel H.J. Mechanism of action of puroindoline derived from tryptophan-rich antimicrobial peptides. Biochim. Biophys. Acta 2013, 1828:1801-1813.
20. Subbalakshmi C., Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 1998, 160:91-96.
21. Shi J., Ross C.R., Chengappa M.M., Sylte M.J., McVey D.S., Blecha F. Antimicrobial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide. Antimicrob. Agents Chemother. 1996, 40:115-121.
22. Li W.F., Ma G.X., Zhou X.X. Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action. Peptides 2006, 27:2350-2359.
23. Otvos L., Roger O.I., Consolvo P.J., Condie B.A., Lovas S., Bulet P., Blaszczyk-Thurin M. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 2000, 39:14150-14159.
24. Kragol G., Lovas S., Varadi G., Condie B.A., Hoffmann R., Otvos L. The antimicrobial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein holding. Biochemistry 2001, 40:3016-3026.
25. Kragol G., Hoffmann R., Chattergoon M.A., Lovas S., Cudic M., Bulet P., Condie B.A., Rosengren K.J., Montaner L.J., Otvos L. Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur. J. Biochem. 2002, 269:4226-4237.
26. Otvos L. The short proline-rich antibacterial peptide family. Cell. Mol. Life Sci. 2002, 59:1138-1150.
27. Scocchi M., Lüthy C., Decarli P., Mignogna G., Christen P., Gennaro R. The proline-rich antimicrobial peptide Bac7 binds to and inhibits in vitro the molecular chaperon DnaK. Int. J. Pept. Res. Ther. 2009, 15:147-155.
28. 1-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem. Biol. 2014, 21:1639-1647.
29. Krizsan A., Volke D., Weinert S., Sträter N., Knappe D., Hoffmann R. Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. Angew. Chem. Int. Ed. 2014, 53:12236-12239.
30. Chesnokova L.S., Slepenkov S.V., Witt S.N. The insect antimicrobial peptide, l-pyrrhocoricin, binds to and stimulate ATPase activity of both wild-type and lidless DnaK. FEMS Lett. 2004, 565:65-69.
31. Liebscher M., Roujeinikova A. Allosteric coupling between the lid and interdomain linker and DnaK revealed by inhibitor binding studies. J. Bacteriol. 2009, 191:1456-1462.
32. Renesto P., Raoult D. From genes to protein: in vitro expression of rickettsial proteins. Ann. N.Y. Acad. Sci. 2003, 990:642-652.
33. Goerke A.R., Swartz J.R. High-level cell-free synthesis yields of proteins containing site-specific non-natural amino acids. Biotechnol. Bioeng. 2009, 102:400-416.
34. Tachibana R., Harashima H., Ishida T., Shinohara Y., Hino M., Terada H., Baba Y., Kiwada H. Effect of cationic liposomes in an in vitro transcription and translation system. Biol. Pharm. Bull. 2002, 25:529-531.
35. Bui H.T., Umakoshi H., Ngo K.X., Nishida M., Shimanouchi T., Kuboi R. Liposome membrane itself can affect gene expression in the Escherichia coli cell-free translation system. Langumuir 2008, 24:10537-10542.
36. Ulvatne H., Samuelsen Ø., Haukland H.H., Krämer M., Vorland L.H. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol. Lett. 2004, 237:377-384.
37. Kohanski M.A., Dwyer D.J., Collins J.J. How antibiotics kill bacteria: from targets to network. Nat. Rev. Microbiol. 2010, 8:423-435.
38. Kawaguchi H., Tsukiura H., Tomita K., Konishi M., Saito K., Kobaru S., Numata K., Fujisawa K., Miyaki T., Hatori M., Koshiyama H. Tallysomysin, a new antitumor antibiotic complex related to bleomyxin. 1. Production, isolation and properties. J. Antibiot. 1977, 30:779-788.
39. Tanaka N., Nakamura S. Determination of antibiotic activity and susceptibility test. Essentials in antibiotics 1992, 16-21. University of Tokyo Press, Tokyo. 4th ed. N. Tanaka, S. Nakamura (Eds.).
40. Lu C.-L., Liu C.-Y., Huang Y.-T., Liao C.-H., Teng L.-J., Turnedge J.D., Hsuch P.-R. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomysin determined by agar dilution and disk dilution methods. Antimicrob. Agents Chemother. 2011, 55:4295-4301.
41. Zahn M., Berthold N., Kieslich B., Knappe D., Hoffmann R., Sträter N. Structure studies on the forward and reverse binding modes of peptides to the chaperon DnaK. J. Mol. Biol. 2013, 425:2463-2479.
42. Bui H.T., Umakoshi H., Suga K., Tanabe T., Ngo K.X., Shimanouchi T., Kuboi R. Cationic liposome can interfere mRNA translation in the Escherichia coli cell-free translation system. Biochem. Eng. J. 2010, 52:38-43.
43. Suzuki H., Nagai K., Yamaki H., Tanaka N., Umezawa H. Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells. J. Antibiot. 1968, 21:379-386.
44. Castle M., Nazarian A., Yi S.S., Tempst P. Lethal effect of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J. Biol. Chem. 1999, 274:32555-32564.
45. Patrzykat A., Friedrich C.L., Zhang L., Mendoza V., Hancock R.E.W. Sublethal concentratration of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 2002, 46:605-614.
46. Pellegrini A., Thomas U., Wild P., Schranerm E., von Fellenberg R. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane peameability of Escherichia coli. Microbiol. Res. 2000, 155:69-77.
47. Mattiuzzo M., Bandiera A., Gennaro R., Benincase M., Pacor S., Antcheva N., Scocchi M. Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol. Microbiol. 2007, 66:151-163.
48. (1-35). J. Bacteriol. 2013, 195:5343-5351.
49. Spindler E.C., Hale J.D.F., Giddings T.H., Hancock R.E.W., Gill R.T. Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c. Antimicrob. Agents Chemother. 2011, 55:1706-1716.
50. Hilpert K., McLoed B., Yu J., Elliott M.R., Rautenbach M., Ruden S., Bürck J., Muhle-Goll G., Ulrich A.S., Keller S., Hancock R.E.W. Short cationic antimicrobial peptides interact with ATP. Antimicrob. Agents Chemother. 2010, 54:4480-4483.
51. Tu Y.-H., Ho Y.-H., Chuang Y.-C., Chen P.-C., Chen C.-S. Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip. Plos One 2011, 6:e28197.